Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lokich

Showing results (11-20 of 157) with videos related to

Pageof 16
Sort By:
Cancer|September 1, 1977
Leukocyte alkaline phosphatase activity in patients with malignant diseaseJ J Lokich
American Journal of Clinical Oncology|October 1, 1985
Optimal schedule for 5-fluorouracil chemotherapy. Intermittent bolus or continuous infusion?J J Lokich
Postgraduate Medicine|February 1, 1990
Improved cancer chemotherapy. Benefits of delivery by infusionJ J Lokich
Oncology|January 1, 1979
Pleural effusion secondary to tumor regressionJ J Lokich
JAMA|July 4, 1977
Pulmonary osteoarthropathy. Association with mesenchymal tumor metastases to the lungsJ J Lokich
American Journal of Clinical Oncology|April 1, 1984
Hepatic artery chemotherapy: the relative importance of direct organ distribution vs. the constant-infusion scheduleJ J Lokich
Oncology|January 1, 1978
Tumor markers: hormones, antigens, and enzymes in malignant diseaseJ J Lokich
Cancer Treatment Reports|August 1, 1980
Phase I study of cis-diamminedichloroplatinum(II) administered as a constant 5-day infusionJ J Lokich
Oncology|January 1, 1978
Osseous metastases: radiographic monitoring of therapeutic responseJ J Lokich
Cancer|November 15, 1982
The frequency and clinical biology of the ectopic hormone syndromes of small cell carcinomaJ J Lokich
Pageof 16

Showing results (11-20 of 157) with videos related to

Sort By:
Pageof 16
Cancer|September 1, 1977
Leukocyte alkaline phosphatase activity in patients with malignant diseaseJ J Lokich
American Journal of Clinical Oncology|October 1, 1985
Optimal schedule for 5-fluorouracil chemotherapy. Intermittent bolus or continuous infusion?J J Lokich
Postgraduate Medicine|February 1, 1990
Improved cancer chemotherapy. Benefits of delivery by infusionJ J Lokich
Oncology|January 1, 1979
Pleural effusion secondary to tumor regressionJ J Lokich
JAMA|July 4, 1977
Pulmonary osteoarthropathy. Association with mesenchymal tumor metastases to the lungsJ J Lokich
American Journal of Clinical Oncology|April 1, 1984
Hepatic artery chemotherapy: the relative importance of direct organ distribution vs. the constant-infusion scheduleJ J Lokich
Oncology|January 1, 1978
Tumor markers: hormones, antigens, and enzymes in malignant diseaseJ J Lokich
Cancer Treatment Reports|August 1, 1980
Phase I study of cis-diamminedichloroplatinum(II) administered as a constant 5-day infusionJ J Lokich
Oncology|January 1, 1978
Osseous metastases: radiographic monitoring of therapeutic responseJ J Lokich
Cancer|November 15, 1982
The frequency and clinical biology of the ectopic hormone syndromes of small cell carcinomaJ J Lokich
Pageof 16